
1. sci rep. 2019 may 7;9(1):7005. doi: 10.1038/s41598-019-42801-x.

high-throughput screening plasmodium falciparum cgmp-dependent protein
kinase identified thiazole scaffold kills erythrocytic sexual stage
parasites.

penzo m(1)(2), de las heras-dueña l(1), mata-cantero l(1), diaz-hernandez b(1),
vazquez-muñiz mj(1), ghidelli-disse s(3), drewes g(3), fernandez-alvaro e(1),
baker da(4).

author information: 
(1)gsk global health, severo ochoa 2, tres cantos 28760 madrid, spain.
(2)faculty infectious tropical diseases, london school hygiene &
tropical medicine, london, wc1e 7ht, united kingdom.
(3)cellzome gmbh, glaxosmithkline company, meyerhofstrasse 1, 69117,
heidelberg, germany.
(4)faculty infectious tropical diseases, london school hygiene &
tropical medicine, london, wc1e 7ht, united kingdom. david.baker@lshtm.ac.uk.

antimalarial drug resistance compels quest new compounds target
alternative pathways current drugs. plasmodium cyclic gmp-dependent
protein kinase (pkg) essential functions major life cycle
developmental stages. imidazopyridine pkg inhibitor scaffold previously
shown clear p. falciparum infection rodent model vivo blocked
transmission mosquitoes providing proof concept target. find
new classes pkg inhibitors serve alternative chemical starting points,
we performed high-throughput screen gsk full diversity collection using 
recombinant p. falciparum pkg. developed robust enzymatic assay a
1536-well plate format. promising compounds tested activity against
p. falciparum asexual blood stage growth, selectivity cytotoxicity. using 
a scoring system selected 66 promising pkg inhibitors (comprising
nine clusters seven singletons). among these, thiazoles potent 
scaffold mid-nanomolar activity p. falciparum blood stage gamete
development. using kinobeads profiling identified additional p. falciparum
protein kinases targeted thiazoles mediate faster speed kill
than pkg-selective compounds. scaffold represents promising starting point
to develop new antimalarial.

doi: 10.1038/s41598-019-42801-x 
pmcid: pmc6504873
pmid: 31065005  [indexed medline]

